Looking for CALR mutations in familial myeloproliferative neoplasms

被引:18
作者
Maffioli, M. [1 ]
Genoni, A. [2 ]
Caramazza, D. [1 ]
Mora, B. [1 ]
Bussini, A. [2 ]
Merli, M. [1 ]
Giorgino, T. [3 ]
Casalone, R. [2 ]
Passamonti, F. [1 ]
机构
[1] Univ Hosp Osped Circolo & Fdn Macchi, Dept Med, Div Hematol, Varese, Italy
[2] Univ Hosp Osped Circolo & Fdn Macchi, Med Genet & Cytogenet Lab, Genet Unit, SSD,SMEL, Varese, Italy
[3] Natl Res Council Italy ISIB CNR, Inst Biomed Engn, Padua, Italy
关键词
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; TET2; GENE; MYELOFIBROSIS; JAK2; DISORDERS;
D O I
10.1038/leu.2014.33
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1357 / 1360
页数:5
相关论文
共 50 条
  • [21] Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
    Klampfl, Thorsten
    Gisslinger, Heinz
    Harutyunyan, Ashot S.
    Nivarthi, Harini
    Rumi, Elisa
    Milosevic, Jelena D.
    Them, Nicole C. C.
    Berg, Tiina
    Gisslinger, Bettina
    Pietra, Daniela
    Chen, Doris
    Vladimer, Gregory I.
    Bagienski, Klaudia
    Milanesi, Chiara
    Casetti, Ilaria Carola
    Sant'Antonio, Emanuela
    Ferretti, Virginia
    Elena, Chiara
    Schischlik, Fiorella
    Cleary, Ciara
    Six, Melanie
    Schalling, Martin
    Schoenegger, Andreas
    Bock, Christoph
    Malcovati, Luca
    Pascutto, Cristiana
    Superti-Furga, Giulio
    Cazzola, Mario
    Kralovics, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) : 2379 - 2390
  • [22] CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms
    Nomani, Laila
    Bodo, Juraj
    Zhao, Xiaoxian
    Durkin, Lisa
    Loghavi, Sanam
    Hsi, Eric D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (04) : 431 - 438
  • [23] The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms
    Lin, Yani
    Liu, Enbin
    Sun, Qi
    Ma, Jiao
    Li, QingHua
    Cao, Zeng
    Wang, Jun
    Jia, Yujiao
    Zhang, Hongju
    Song, Zhen
    Ai, Xiaofei
    Shi, Lihui
    Feng, Xiaofang
    Li, Chenwei
    Wang, Jianxiang
    Ru, Kun
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (01) : 165 - 171
  • [24] Capricious CALR mutated clones in myeloproliferative neoplasms
    Haslam, Karl
    Conneally, Eibhlin
    Langabeer, Stephen E.
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 57 : 110 - 111
  • [25] Role of TET2 and ASXL1 Mutations in the Pathogenesis of Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Mu, Ayalew Tefferi
    Levine, Ross L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1053 - +
  • [26] The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review
    Najim, Mostafa
    Abu-Tineh, Mohammad
    Alshurafa, Awni
    Ibrahim, Mohamed Izham Mohamed
    Ansari, Soubiya
    Faraj, Hazem
    Alateeg, Saif
    Akiki, Susanna Jane
    Yassin, Mohamed A.
    HEMATOLOGY, 2024, 29 (01)
  • [27] An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
    Tefferi, A.
    Thiele, J.
    Vannucchi, A. M.
    Barbui, T.
    LEUKEMIA, 2014, 28 (07) : 1407 - 1413
  • [28] Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR
    Murugesan, G.
    Guenther-Johnson, J.
    Mularo, F.
    Cook, J. R.
    Daly, T. M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (03) : 284 - 297
  • [29] Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
    Pietra, D.
    Rumi, E.
    Ferretti, V. V.
    Di Buduo, C. A.
    Milanes, C.
    Cavalloni, C.
    Sant'Antonio, E.
    Abbonante, V.
    Moccia, F.
    Casetti, I. C.
    Bellini, M.
    Renna, M. C.
    Roncoroni, E.
    Fugazza, E.
    Astori, C.
    Boveri, E.
    Rosti, V.
    Barosi, G.
    Balduini, A.
    Cazzola, M.
    LEUKEMIA, 2016, 30 (02) : 431 - 438
  • [30] Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
    Tenedini, E.
    Bernardis, I.
    Artusi, V.
    Artuso, L.
    Roncaglia, E.
    Guglielmelli, P.
    Pieri, L.
    Bogani, C.
    Biamonte, F.
    Rotunno, G.
    Mannarelli, C.
    Bianchi, E.
    Pancrazzi, A.
    Fanelli, T.
    Tagliazucchi, G. Malagoli
    Ferrari, S.
    Manfredini, R.
    Vannucchi, A. M.
    Tagliafico, E.
    LEUKEMIA, 2014, 28 (05) : 1052 - 1059